Trials / Unknown
UnknownNCT01945788
Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo
Comparación de la Eficacia y Seguridad clínicas de Osteofortil Respecto de Forteo
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Bio Sidus SA · Industry
- Sex
- Female
- Age
- 50 Years – 81 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare efficacy and safety of two formulations of teriparatide 20 mcg/day plus calcium and vitamin D in postmenopausal women with osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teriparatide (rDNA origin) |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-11-01
- First posted
- 2013-09-19
- Last updated
- 2014-01-22
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT01945788. Inclusion in this directory is not an endorsement.